Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹28,775.3
₹61,146 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,577.7
₹44,698 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,675.1
₹30,088 Cr
Pharmaceuticals & Drugs
₹833.4
₹16,382 Cr
Pharmaceuticals & Drugs
₹1,145.4
₹14,059 Cr
Pharmaceuticals & Drugs
₹694.6
₹10,932 Cr
Pharmaceuticals & Drugs
₹704.7
₹6,390 Cr
Pharmaceuticals & Drugs
₹426.6
₹3,893 Cr
Pharmaceuticals & Drugs
₹321.5
₹3,599 Cr
Pharmaceuticals & Drugs
₹693.0
₹395 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹833.4
₹7,345 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,577.7
₹5,453 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹694.6
₹4,359 Cr
Pharmaceuticals & Drugs
₹426.6
₹2,565 Cr
Pharmaceuticals & Drugs
₹704.7
₹1,819 Cr
Pharmaceuticals & Drugs
₹3,675.1
₹1,339 Cr
Pharmaceuticals & Drugs
₹321.5
₹746 Cr
Pharmaceuticals & Drugs
₹28,775.3
₹6,929 Cr
Pharmaceuticals & Drugs
₹693.0
₹334 Cr
Pharmaceuticals & Drugs
₹1,145.4
₹2,552 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,577.7
₹1,056 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹833.4
₹671 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,675.1
₹356 Cr
Pharmaceuticals & Drugs
₹694.6
₹256 Cr
Pharmaceuticals & Drugs
₹426.6
₹195 Cr
Pharmaceuticals & Drugs
₹704.7
₹179 Cr
Pharmaceuticals & Drugs
₹321.5
₹174 Cr
Pharmaceuticals & Drugs
₹28,775.3
₹1,552 Cr
Pharmaceuticals & Drugs
₹693.0
₹-1 Cr
Pharmaceuticals & Drugs
₹1,145.4
₹564 Cr

You may also like the below Video Courses